A 5-ft 1-in, 183-lb 14-year-old girl was concerned about the areas of thickened hyperpigmentation on her posterior neck and in her cleavage.
A 5-ft 1-in, 183-lb 14-year-old girl was concerned about the areas of thickened hyperpigmentation on her posterior neck and in her cleavage.
The lesions had a velvety appearance and were asymptomatic. She was not taking any medications. In the past, she had been told to apply a combination of lactic acid and urea to the areas; this treatment resulted in a softening of the affected skin but did not reduce the hyperpigmentation.
Yearly measurements of blood glucose and insulin had been normal. These findings were consistent with a benign acanthosis nigricans.
Acanthosis nigricans, a nonspecific increase in the thickness of the prickle cell layer of the skin, is most commonly associated with obesity. It is also known to develop in persons with diabetes, corticosteroid excess, pineal tumors, endocrine disorders, and genetic variants; nicotinic acid and estrogen may also induce these pigmentary changes. The hyperpigmentation typically involves the axillae; however, it may arise in flexural areas of the neck and groin, the belt line, dorsum of the finger, around the umbilicus and the areola of the breast, and in the mouth.
Most cases of benign acanthosis nigricans are caused by heat and friction in the flexural folds. Losing weight can help reduce skin friction and promote spontaneous resolution of the hyperpigmentation. This patient was advised to lose weight with diet and exercise.
Young woman with tick bites presents with erythematous papules, headaches, and fatigue
April 8th 2024A young woman with no significant past medical history returns from hiking with several white-spotted ticks and experiences erythematous papules, rashes, headaches, and fatigue. What’s the diagnosis?
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color
March 8th 2024Data from a pair of identical, phase 3, double-blind, randomized, and vehicle-controlled trials were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California.